François Ravat

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

P. Jault, Thomas Leclerc, Serge Jennes et al. · The Lancet Infectious Diseases · 2018 · 843 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

36th International Symposium on Intensive Care and Emergency Medicine

R. M. Bateman, Michael D. Sharpe, Justin E. Jagger et al. · Critical Care · 2016 · 521 citations · Full text

Life Sciences, Pharmacology, Physiology +17

Estimation of blood loss during adult burn surgery

Boris Farny, Mathieu Fontaine, J Latarjet et al. · Burns · 2018 · 34 citations

Medicine, Perioperative Medicine, Surgery +13

Clinical pharmacokinetics of ciprofloxacin in patients with major burns

A. Lesne-Hulin, Philippe Bourget, François Ravat et al. · European Journal of Clinical Pharmacology · 1999 · 20 citations

Medicine, Clinical Pharmacokinetics, Pharmacokinetics +12

Ceftazidime Dosage Recommendations in Burn Patients: From a Population Pharmacokinetic Approach to Clinical Practice via Monte Carlo Simulations

Jean‐Marie Conil, Bernard Georges, François Ravat et al. · Clinical Therapeutics · 2013 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +17